TG Therapeutics Inc (NASDAQ:TGTX)

15.93
Delayed Data
As of May 22
 -0.07 / -0.44%
Today’s Change
5.04
Today|||52-Week Range
20.00
+0.57%
Year-to-Date
No recent news for TG Therapeutics Inc.

Today’s Trading

Previous close16.00
Today’s open16.00
Day’s range-- - --
Volume384,759
Average volume (3 months)614,480
Market cap$806.6M
Dividend yield--
Data as of 05/22/2015

Growth & Valuation

Earnings growth (last year)-102.47%
Earnings growth (this year)+22.87%
Earnings growth (next 5 years)--
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales3,541.46
Price/Book8.94

Competitors

 Today’s
change
Today’s
% change
OMEROmeros Corp-0.02-0.09%
COCPCocrystal Pharma Inc-0.03-2.56%
EPZMEpizyme Inc+0.10+0.53%
ZFGNZafgen Inc+0.82+2.69%
Data as of 3:59pm ET, 05/22/2015

Financials

Next reporting dateJuly 30, 2015
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$152.4K
Annual profit (last year)-$55.8M
Net profit margin-36,606.45%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman, President &
CEO
Michael S. Weiss
CFO, Secretary, Treasurer &
CAO
Sean A. Power
Corporate headquarters
New York, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers